Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
BioPharmaceutical North America United States

Antibiotic Recipe For High Prices: Outcomes Data, Targeted Use

  • News

Executive Summary

Drug developers must show value, such as lower death rates, to justify high prices for antibiotics to treat drug resistant organisms, payers note during conference on the Limited Population Antibacterial Drug approval pathway.

Table

View full table

Advertisement

Related Content

Pink Sheet
Antibiotic Incentive Legislation: Can Reimbursement Horn In?
Pink Sheet
Antibiotics For Drug-Resistant Infections Hope To Skip Phase III Trials
Pink Sheet
With GAIN In Place, Antibiotic Improvements Depend On FDA Implementation
Pink Sheet
Optimer’s Dificid Gets Medicare Payment “Add-On” For Hospital Patients
Pink Sheet
Antibiotic Incentives: FDA’s Woodcock Says LPAD Could Be Better Than Exclusivity, But Questions Remain
Pink Sheet
Optimer’s Dificid Could Pave A Path To Higher Prices For Antibiotics

Topics

Related Companies

Advertisement
Tags:
BioPharmaceutical North America United States
UsernamePublicRestriction

Register

PS055076

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By